RHABDOMYOSARCOMA
Clinical trials for RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major cancer trial tests if more chemo in less time beats less chemo over more time
Disease control Not yet recruitingThis study aims to find the best chemotherapy plan for patients newly diagnosed with intermediate-risk rhabdomyosarcoma, a rare cancer that mostly affects children and young adults. It will compare a shorter, more intense treatment to a longer, less intense treatment that include…
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Scientists supercharge Patient's own cells to battle tough cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of cell therapy for adults with advanced solid tumors that have not responded to standard treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack their cancer, and …
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough childhood cancer: experimental combo targets High-Risk tumors
Disease control Not yet recruitingThis study is testing whether adding a vitamin A-based drug (all-trans retinoic acid) to standard chemotherapy (VAC regimen) works better against intermediate-to-high-risk rhabdomyosarcoma, a rare but aggressive muscle cancer. It will involve 106 patients aged 14-60 who haven't h…
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Glowing dye trial aims to guide surgeons in delicate pediatric cancer operations
Diagnosis Not yet recruitingThis study is testing whether a special green dye can safely and effectively help surgeons see the first lymph nodes that cancer might spread to in children with solid tumors. During surgery, the dye is injected near the tumor and glows under a special camera, highlighting these …
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE1 • Sponsor: University of Rochester • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC